.

S16 - PSC FARIDABAD SECTOR 37

SHOP NO. 23, SECTOR 37, HUDA MARKET,
FAR IDABAD, HARYANA - 121003
FARIDABAD 121003

Name : Mrs. VEENA Collected : 8/6/2017 9:17:00AM

Received : 8/6/2017 9:37:53AM
Lab No. : 136464772 Age: 57 Years Gender: Female Reported : 8/6/2017 3:29:21PM
A/c Status : P Ref By : Dr. HOLY FAMLIY HOSPITAL Report Status : Final

Test Name Results Units Bio. Ref. Interval

LIPID PROFILE, BASIC, SERUM

(Spectrophotometry, Calculated)
Cholesterol Total 273.00 mg/dL <200.00
Triglycerides 112.00 mg/dL <150.00
HDL Cholesterol 61.00 mg/dL >50.00
LDL Cholesterol 194.00 mg/dL <100.00
VLDL Cholesterol 18.00 mg/dL <30.00
Non-HDL Cholesterol 212.00 mg/dL <130.00
Interpretation
-----------------------------------------------------------------------------------
| NATIONAL LIPID | TOTAL | TRIGLYCERIDE | LDL CHOLESTEROL |NON HDL |
| ASSOCIATION | CHOLESTEROL | in mg/dL | in mg/dL |CHOLESTEROL |
| RECOMMENDATIONS | in mg/dL | | |in mg/dL |
| (NLA-2014) | | | | |
|-------------------|---------------|--------------|-----------------|--------------|
| Optimal | <200 | <150 | <100 | <130 |
|-------------------|---------------|--------------|-----------------|--------------|
| Above Optimal | - | - | 100- 129 | 130 - 159 |
|-------------------|---------------|--------------|-----------------|--------------|
| Borderline High | 200-239 | 150-199 | 130-159 | 160 - 189 |
|-------------------|---------------|--------------|-----------------|--------------|
| High | >=240 | 200-499 | 160-189 | 190 - 219 |
|-------------------|---------------|--------------|-----------------|--------------|
| Very High | - | >=500 | >=190 | >=220 |
-----------------------------------------------------------------------------------

Note
1. Measurements in the same patient can show physiological& analytical variations. Three serial samples
1 week apart are recommended for Total Cholesterol, Triglycerides, HDL& LDL Cholesterol.
2. As per NLA-2014 guidelines, all adults above the age of 20 years should be screened for lipid status.
Selective screening of children above the age of 2 years with a family history of premature
cardiovascular disease or those with at least one parent with high total cholesterol is recommended.
3. Low HDL levels are associated with increased risk forAtherosclerotic Cardiovascular disease (ASCVD)
due to insufficient HDL being available to participate in reverse cholesterol transport, the process by
which cholesterol is eliminated from peripheral tissues.
4. NLA-2014identifies Non HDL Cholesterol(an indicator of all atherogeniclipoproteins such as LDL , VLDL,
IDL, Lpa, Chylomicron remnants)along with LDL-cholesterol as co- primary target for cholesterol
lowering therapy. Note that major risk factors can modify treatment goals for LDL &Non HDL.
5. Apolipoprotein B is an optional, secondary lipid target for treatment once LDL & Non HDL goals have
been achieved.
6. Additional testing for Apolipoprotein B, hsCRP,Lp(a ) & LP-PLA2 should be considered among patients
with moderate risk for ASCVD for risk refinement
PatientReportSCSuperPanel.GENERAL_PANEL_ANALYTE_SC (Version: 6)

*136464772* Page 1 of 5
.

S16 - PSC FARIDABAD SECTOR 37

SHOP NO. 23, SECTOR 37, HUDA MARKET,
FAR IDABAD, HARYANA - 121003
FARIDABAD 121003

Name : Mrs. VEENA Collected : 8/6/2017 9:17:00AM

Received : 8/6/2017 9:37:53AM
Lab No. : 136464772 Age: 57 Years Gender: Female Reported : 8/6/2017 3:29:21PM
A/c Status : P Ref By : Dr. HOLY FAMLIY HOSPITAL Report Status : Final

Test Name Results Units Bio. Ref. Interval

Treatment Goals as per NLA 2014

----------------------------------------------------------------------------------------
| RISK CATEGORY | NON HDL CHLOESTEROL | LDL CHOLESTEROL |APOLIPOPROTEIN B (mg/dL) |
| | (NON HDL-C) (mg/dL) | (LDL-C)(mg/dL) | |
|----------------------|---------------------|-----------------|-------------------------|
| Low/Moderate/High | <130 | <100 | <90 |
|----------------------|---------------------|-----------------|-------------------------|
| Very High | <100 | <70 | <80 |
----------------------------------------------------------------------------------------

PatientReportSCSuperPanel.GENERAL_PANEL_ANALYTE_SC (Version: 6)

*136464772* Page 2 of 5
.

S16 - PSC FARIDABAD SECTOR 37

SHOP NO. 23, SECTOR 37, HUDA MARKET,
FAR IDABAD, HARYANA - 121003
FARIDABAD 121003

Name : Mrs. VEENA Collected : 8/6/2017 9:17:00AM

Received : 8/6/2017 9:37:53AM
Lab No. : 136464772 Age: 57 Years Gender: Female Reported : 8/6/2017 3:29:21PM
A/c Status : P Ref By : Dr. HOLY FAMLIY HOSPITAL Report Status : Final

Test Name Results Units Bio. Ref. Interval

THYROID PROFILE, FREE, SERUM @

(CLIA)

T3, Free; FT3 2.88 pg/mL 2.30 - 4.20

T4, Free; FT4 1.08 ng/dL 0.89 - 1.76

TSH, Ultrasensitive 1.516 uIU/mL 0.550 - 4.780

Note
1. TSH levels are subject to circadian variation, reaching peak levels between 2 - 4.a.m. and at a
minimum between 6-10 pm. The variation is of the order of 50%. hence time of the day has influence
on the measured serum TSH concentrations.

2. TSH Values <0.03 uIU/mL need to be clinically correlated due to presence of a rare TSH variant in
some individuals

Clinical Use
Primary Hypothyroidism
Hyperthyroidism
Hypothalamic - Pituitary hypothyroidism
Inappropriate TSH secretion
Nonthyroidal illness
Autoimmune thyroid disease
Pregnancy associated thyroid disorders
Thyroid dysfunction in infancy and early childhood

VITAMIN D, 25 - HYDROXY, SERUM @ 15.23 nmol/L

(CLIA)
Interpretation
-------------------------------------------------------------
| LEVEL | REFERENCE RANGE | COMMENTS |
| | IN nmol/L | |
|---------------|-----------------|---------------------------|
| Deficient | < 50 | High risk for developing |
| | | bone disease |
|---------------|-----------------|---------------------------|
| Insufficient | 50-74 | Vitamin D concentration |
| | | which normalizes |
| | | Parathyroid hormone |
PatientReportSCSuperPanel.SP_GENERAL_TEMPLATE01_SC (Version: 7)

*136464772* Page 3 of 5
.

S16 - PSC FARIDABAD SECTOR 37

SHOP NO. 23, SECTOR 37, HUDA MARKET,
FAR IDABAD, HARYANA - 121003
FARIDABAD 121003

Name : Mrs. VEENA Collected : 8/6/2017 9:17:00AM

Received : 8/6/2017 9:37:53AM
Lab No. : 136464772 Age: 57 Years Gender: Female Reported : 8/6/2017 3:29:21PM
A/c Status : P Ref By : Dr. HOLY FAMLIY HOSPITAL Report Status : Final

Test Name Results Units Bio. Ref. Interval

| | | concentration |
|---------------|-----------------|---------------------------|
| Sufficient | 75-250 | Optimal concentration |
| | | for maximal health benefit|
|---------------|-----------------|---------------------------|
| Potential | >250 | High risk for toxic |
| intoxication | | effects |
-------------------------------------------------------------

Note
The assay measures both D2 (Ergocalciferol) and D3 (Cholecalciferol) metabolites of vitamin D.
25 (OH)D is influenced by sunlight, latitude, skin pigmentation, sunscreen use and hepatic function.
Optimal calcium absorption requires vitamin D 25 (OH) levels exceeding 75 nmol/L.
It shows seasonal variation, with values being 40-50% lower in winter than in summer.
Levels vary with age and are increased in pregnancy.
A new test Vitamin D, Ultrasensitive by LC-MS/MS is also available

Comments
Vitamin D promotes absorption of calcium and phosphorus and mineralization of bones and teeth. Deficiency
in children causes Rickets and in adults leads to Osteomalacia. It can also lead to Hypocalcemia and
Tetany. Vitamin D status is best determined by measurement of 25 hydroxy vitamin D, as it is the major
circulating form and has longer half life (2-3 weeks) than 1,25 Dihydroxy vitamin D (5-8 hrs).

Decreased Levels
Inadequate exposure to sunlight
Dietary deficiency
Vitamin D malabsorption
Severe Hepatocellular disease
Drugs like Anticonvulsants
Nephrotic syndrome

Increased levels
Vitamin D intoxication

PatientReportSCSuperPanel.SP_GENERAL_TEMPLATE01_SC (Version: 7)

*136464772* Page 4 of 5
.

S16 - PSC FARIDABAD SECTOR 37

SHOP NO. 23, SECTOR 37, HUDA MARKET,
FAR IDABAD, HARYANA - 121003
FARIDABAD 121003

Name : Mrs. VEENA Collected : 8/6/2017 9:17:00AM

Received : 8/6/2017 9:37:53AM
Lab No. : 136464772 Age: 57 Years Gender: Female Reported : 8/6/2017 3:29:21PM
A/c Status : P Ref By : Dr. HOLY FAMLIY HOSPITAL Report Status : Final

Test Name Results Units Bio. Ref. Interval

Dr Himangshu Mazumdar Dr. Nimmi Kansal Dr Ravindra Kumar Agrawal

MD (Biochemistry) MD (Biochemistry) MD (Pathology)
Consultant Biochemist HOD Biochem & IA Chief of Lab

-------------------------------End of report --------------------------------

PatientReportSCSuperPanel.SP_GENERAL_TEMPLATE01_SC (Version: 7)

*136464772* Page 5 of 5